Arcutis Biotherapeutics, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
ARQT on Nasdaq
Industry
Pharmaceutical Preparations
Location
3027 Townsgate Road, Suite 300, Westlake Village, CA

Insiders trading volume in the past year

Arcutis Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Patrick J. Heron Director $122M +$373K +0.31% Jun 13, 2025
Frazier Life Sciences VIII, L.P. 10%+ Owner $31.3M Oct 24, 2023
Todd Franklin Watanabe Reporting Person's title: President and Chief Executive Officer, Director $20.1M -$2.39M -10.6% Oct 1, 2025
Bhaskar Chaudhuri Director $12.7M Jun 12, 2025
David Topper Chief Financial Officer $2.89M -$152K -4.99% Apr 2, 2025
Masaru Matsuda Reporting Person's title: SVP General Counsel and Corporate Secretary $2.6M -$973K -27.2% Sep 4, 2025
Larry Todd Edwards Reporting Person's title: EVP Chief Commercial Officer $2.58M -$125K -4.62% May 19, 2025
Howard G. Welgus Director $1.89M -$1.66M -46.9% Oct 1, 2025
Patrick Burnett Reporting Person's Title: Executive Vice President and Chief Medical Officer $1.63M -$2.84M -63.5% Aug 19, 2025
Orbimed Advisors Llc 10%+ Owner $1.47M Jun 24, 2022
Matthew Richard Moore SVP and Chief Business Officer $1.27M May 1, 2024
David W. Osborne Chief Technical Officer $952K Mar 6, 2023
Latha Vairavan SVP Chief Financial Officer $931K -$1.28K -0.14% Aug 4, 2025
John W. Smither Chief Financial Officer $541K Feb 13, 2024
R. Keith Leonard Director $390K Jun 12, 2025
Sue Jean Lin Director $369K Jun 12, 2025
Halley E. Gilbert Director $365K Jun 12, 2025
Neha Krishnamohan Director $323K Jun 12, 2025
Terrie Curran Director $245K -$94.2K -27.8% Jun 12, 2025
Kenneth A. Lock Chief Commercial Officer $225K Mar 6, 2023
Patricia A. Turney SVP, Operations $223K Mar 6, 2023
Scott L. Burrows Chief Financial Officer $209K Mar 6, 2023
Joseph L. Turner Director $15.3K Jun 1, 2022
Ricky Sun Director Jun 9, 2021

Recent Insider Transactions by Companies or Individuals for Arcutis Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.